Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.73 +0.00 (+0.00%)
As of: Oct 20, 2026 · 3:54 PM EDT

Processa Pharmaceuticals (PCSA) Capital Expenditures (2012 - 2015)

Updated

Processa Pharmaceuticals (PCSA) posted Capital Expenditures of $3,244 for FY2024, up 16.9% from $2,776 in FY2023.

Analysis

Processa Pharmaceuticals (PCSA) Capital Expenditures (2012 - 2015) Analysis & Trends

Since FY2012, Processa Pharmaceuticals has reported Capital Expenditures for 7 years.

  • The FY2024 figure stands as the highest annual Capital Expenditures since FY2017.
  • Business Quant data shows PCSA's Capital Expenditures at $2,776 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 1.32 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 322.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 140.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 533.00 Mn
10 Processa Pharmaceuticals 4.76 Mn -8.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 1,399.00
Dec 31, 2014 -14,712.00
Sep 30, 2014 9,947.00
Jun 30, 2014 2,000.00
Mar 31, 2014 13,772.00
Dec 31, 2013 1.00
Sep 30, 2013 20,341.00
Jun 30, 2013 1,056.00
Mar 31, 2013 6,276.00
Dec 31, 2012 14,376.00
Sep 30, 2012 244,273.00
API Access

Processa Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PCSA&period=max&api_key=YOUR_API_KEY